Human mesenchymal stromal cells suppress T-cell proliferation independent of heme oxygenase-1
Mesenchymal stromal cells deploy immune suppressive properties amenable for use as cell therapy for inflammatory disorders. It is now recognized that mesenchymal stromal cells necessitate priming with an inflammatory milieu, in particular interferon-γ, to exert augmented immunosuppressive effects. I...
Saved in:
| Published in | Cytotherapy (Oxford, England) Vol. 17; no. 4; pp. 382 - 391 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Elsevier Inc
01.04.2015
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Mesenchymal stromal cells deploy immune suppressive properties amenable for use as cell therapy for inflammatory disorders. It is now recognized that mesenchymal stromal cells necessitate priming with an inflammatory milieu, in particular interferon-γ, to exert augmented immunosuppressive effects. It has been recently suggested that the heme-catabolizing enzyme heme oxygenase-1 is an essential component of the mesenchymal stromal cell–driven immune suppressive response. Because mesenchymal stromal cells upregulate indoleamine 2,3-dioxygenase expression on interferon-γ priming and indoleamine 2,3-dioxygenase requires heme as a cofactor for optimal catabolic function, we investigated the potential antagonism of heme oxygenase-1 activity on indoleamine 2, 3-dioxygenase and the impact on mesenchymal stromal cell immune plasticity. We herein sought to evaluate the molecular genetic effect of cytokine priming on human mesenchymal stromal cell heme oxygenase-1 expression and its functional role in differentially primed mesenchymal stromal cells. Contrary to previous reports, messenger RNA and protein analyses demonstrated that mesenchymal stromal cells derived from normal subjects (n = 6) do not express heme oxygenase-1 at steady state or after interferon-γ, tumor necrosis factor-α, and/or transforming growth factor-β priming. Pharmacological inhibition of heme oxygenase-1 with the use of tin protoporphyrin did not significantly abrogate the ability of mesenchymal stromal cells to suppress T-cell proliferation in vitro. Overall, these results unequivocally demonstrate that under steady state and after cytokine priming, human mesenchymal stromal cells immunoregulate T-cell proliferation independent of heme oxygenase-1. |
|---|---|
| AbstractList | Mesenchymal stromal cells deploy immune suppressive properties amenable for use as cell therapy for inflammatory disorders. It is now recognized that mesenchymal stromal cells necessitate priming with an inflammatory milieu, in particular interferon-γ, to exert augmented immunosuppressive effects. It has been recently suggested that the heme-catabolizing enzyme heme oxygenase-1 is an essential component of the mesenchymal stromal cell–driven immune suppressive response. Because mesenchymal stromal cells upregulate indoleamine 2,3-dioxygenase expression on interferon-γ priming and indoleamine 2,3-dioxygenase requires heme as a cofactor for optimal catabolic function, we investigated the potential antagonism of heme oxygenase-1 activity on indoleamine 2, 3-dioxygenase and the impact on mesenchymal stromal cell immune plasticity. We herein sought to evaluate the molecular genetic effect of cytokine priming on human mesenchymal stromal cell heme oxygenase-1 expression and its functional role in differentially primed mesenchymal stromal cells. Contrary to previous reports, messenger RNA and protein analyses demonstrated that mesenchymal stromal cells derived from normal subjects (n = 6) do not express heme oxygenase-1 at steady state or after interferon-γ, tumor necrosis factor-α, and/or transforming growth factor-β priming. Pharmacological inhibition of heme oxygenase-1 with the use of tin protoporphyrin did not significantly abrogate the ability of mesenchymal stromal cells to suppress T-cell proliferation in vitro. Overall, these results unequivocally demonstrate that under steady state and after cytokine priming, human mesenchymal stromal cells immunoregulate T-cell proliferation independent of heme oxygenase-1. Mesenchymal stromal cells deploy immune suppressive properties amenable for use as cell therapy for inflammatory disorders. It is now recognized that mesenchymal stromal cells necessitate priming with an inflammatory milieu, in particular interferon-γ, to exert augmented immunosuppressive effects. It has been recently suggested that the heme-catabolizing enzyme heme oxygenase-1 is an essential component of the mesenchymal stromal cell-driven immune suppressive response. Because mesenchymal stromal cells upregulate indoleamine 2,3-dioxygenase expression on interferon-γ priming and indoleamine 2,3-dioxygenase requires heme as a cofactor for optimal catabolic function, we investigated the potential antagonism of heme oxygenase-1 activity on indoleamine 2, 3-dioxygenase and the impact on mesenchymal stromal cell immune plasticity. We herein sought to evaluate the molecular genetic effect of cytokine priming on human mesenchymal stromal cell heme oxygenase-1 expression and its functional role in differentially primed mesenchymal stromal cells. Contrary to previous reports, messenger RNA and protein analyses demonstrated that mesenchymal stromal cells derived from normal subjects (n = 6) do not express heme oxygenase-1 at steady state or after interferon-γ, tumor necrosis factor-α, and/or transforming growth factor-β priming. Pharmacological inhibition of heme oxygenase-1 with the use of tin protoporphyrin did not significantly abrogate the ability of mesenchymal stromal cells to suppress T-cell proliferation in vitro. Overall, these results unequivocally demonstrate that under steady state and after cytokine priming, human mesenchymal stromal cells immunoregulate T-cell proliferation independent of heme oxygenase-1.Mesenchymal stromal cells deploy immune suppressive properties amenable for use as cell therapy for inflammatory disorders. It is now recognized that mesenchymal stromal cells necessitate priming with an inflammatory milieu, in particular interferon-γ, to exert augmented immunosuppressive effects. It has been recently suggested that the heme-catabolizing enzyme heme oxygenase-1 is an essential component of the mesenchymal stromal cell-driven immune suppressive response. Because mesenchymal stromal cells upregulate indoleamine 2,3-dioxygenase expression on interferon-γ priming and indoleamine 2,3-dioxygenase requires heme as a cofactor for optimal catabolic function, we investigated the potential antagonism of heme oxygenase-1 activity on indoleamine 2, 3-dioxygenase and the impact on mesenchymal stromal cell immune plasticity. We herein sought to evaluate the molecular genetic effect of cytokine priming on human mesenchymal stromal cell heme oxygenase-1 expression and its functional role in differentially primed mesenchymal stromal cells. Contrary to previous reports, messenger RNA and protein analyses demonstrated that mesenchymal stromal cells derived from normal subjects (n = 6) do not express heme oxygenase-1 at steady state or after interferon-γ, tumor necrosis factor-α, and/or transforming growth factor-β priming. Pharmacological inhibition of heme oxygenase-1 with the use of tin protoporphyrin did not significantly abrogate the ability of mesenchymal stromal cells to suppress T-cell proliferation in vitro. Overall, these results unequivocally demonstrate that under steady state and after cytokine priming, human mesenchymal stromal cells immunoregulate T-cell proliferation independent of heme oxygenase-1. Abstract Mesenchymal stromal cells deploy immune suppressive properties amenable for use as cell therapy for inflammatory disorders. It is now recognized that mesenchymal stromal cells necessitate priming with an inflammatory milieu, in particular interferon-γ, to exert augmented immunosuppressive effects. It has been recently suggested that the heme-catabolizing enzyme heme oxygenase-1 is an essential component of the mesenchymal stromal cell–driven immune suppressive response. Because mesenchymal stromal cells upregulate indoleamine 2,3-dioxygenase expression on interferon-γ priming and indoleamine 2,3-dioxygenase requires heme as a cofactor for optimal catabolic function, we investigated the potential antagonism of heme oxygenase-1 activity on indoleamine 2, 3-dioxygenase and the impact on mesenchymal stromal cell immune plasticity. We herein sought to evaluate the molecular genetic effect of cytokine priming on human mesenchymal stromal cell heme oxygenase-1 expression and its functional role in differentially primed mesenchymal stromal cells. Contrary to previous reports, messenger RNA and protein analyses demonstrated that mesenchymal stromal cells derived from normal subjects ( n = 6) do not express heme oxygenase-1 at steady state or after interferon-γ, tumor necrosis factor-α, and/or transforming growth factor-β priming. Pharmacological inhibition of heme oxygenase-1 with the use of tin protoporphyrin did not significantly abrogate the ability of mesenchymal stromal cells to suppress T-cell proliferation in vitro . Overall, these results unequivocally demonstrate that under steady state and after cytokine priming, human mesenchymal stromal cells immunoregulate T-cell proliferation independent of heme oxygenase-1. Mesenchymal stromal cells deploy immune suppressive properties amenable for use as cell therapy for inflammatory disorders. It is now recognized that mesenchymal stromal cells necessitate priming with an inflammatory milieu, in particular interferon-γ, to exert augmented immunosuppressive effects. It has been recently suggested that the heme-catabolizing enzyme heme oxygenase-1 is an essential component of the mesenchymal stromal cell-driven immune suppressive response. Because mesenchymal stromal cells upregulate indoleamine 2,3-dioxygenase expression on interferon-γ priming and indoleamine 2,3-dioxygenase requires heme as a cofactor for optimal catabolic function, we investigated the potential antagonism of heme oxygenase-1 activity on indoleamine 2, 3-dioxygenase and the impact on mesenchymal stromal cell immune plasticity. We herein sought to evaluate the molecular genetic effect of cytokine priming on human mesenchymal stromal cell heme oxygenase-1 expression and its functional role in differentially primed mesenchymal stromal cells. Contrary to previous reports, messenger RNA and protein analyses demonstrated that mesenchymal stromal cells derived from normal subjects (n = 6) do not express heme oxygenase-1 at steady state or after interferon-γ, tumor necrosis factor-α, and/or transforming growth factor-β priming. Pharmacological inhibition of heme oxygenase-1 with the use of tin protoporphyrin did not significantly abrogate the ability of mesenchymal stromal cells to suppress T-cell proliferation in vitro. Overall, these results unequivocally demonstrate that under steady state and after cytokine priming, human mesenchymal stromal cells immunoregulate T-cell proliferation independent of heme oxygenase-1. |
| Author | Copland, Ian B. Garcia, Marco A. Galipeau, Jacques Metz, Richard Patel, Seema R. |
| Author_xml | – sequence: 1 givenname: Seema R. surname: Patel fullname: Patel, Seema R. organization: Departments of Hematology & Medical Oncology, Emory University Winship Cancer Institute, Atlanta, Georgia, USA – sequence: 2 givenname: Ian B. surname: Copland fullname: Copland, Ian B. organization: Departments of Hematology & Medical Oncology, Emory University Winship Cancer Institute, Atlanta, Georgia, USA – sequence: 3 givenname: Marco A. surname: Garcia fullname: Garcia, Marco A. organization: Departments of Hematology & Medical Oncology, Emory University Winship Cancer Institute, Atlanta, Georgia, USA – sequence: 4 givenname: Richard surname: Metz fullname: Metz, Richard organization: NewLink Genetics Inc, Plymouth Meeting, Pennsylvania, USA – sequence: 5 givenname: Jacques surname: Galipeau fullname: Galipeau, Jacques email: jgalipe@emory.edu organization: Departments of Hematology & Medical Oncology, Emory University Winship Cancer Institute, Atlanta, Georgia, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25595329$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkk-L1TAUxYOMOH_0C7iQLt205qZNmiciyKCOMODCt5WQl9w6qW1Sk1bstzedN7oYcNzkhnDOvYdf7jk58cEjIc-BVkBBvOqr3qxzxSg0FUBFgT4iZ9C0bcm4ECfbXfCyZs3ulJyn1FPKqJT8CTllnO94zXZn5OvVMmpfjJjQm5t11EOR5hi2anAYUpGWaYqYUrEvt4diimFwHUY9u-AL5y1OmA8_F6ErbnDEIvxav6HXCUt4Sh53ekj47K5ekP2H9_vLq_L688dPl--uS5NTzCXKg-jAtrXupLRtjmY5SG41s6ZjViMXmgvZMl2bRksh7IF2tQSQlneG1Rfk5bFtDvdjwTSr0aUtrfYYlqRACCYa2gLP0hd30uUwolVTdKOOq_pDJAvYUWBiSCli91cCVG3YVa827GrDrgBUxp5N8p7JuPmW0By1Gx62vjlaMfP56TCqZFz-C7QuopmVDe5h-9t7djM474wevuOKqQ9L9Jm8ApWYourLthLbRkBD8y7cNnj97wb_m_4bfs_HQQ |
| CitedBy_id | crossref_primary_10_1016_j_jcyt_2015_11_013 crossref_primary_10_1186_s13287_015_0219_6 crossref_primary_10_3390_app10249040 crossref_primary_10_3389_fimmu_2019_00619 crossref_primary_10_2217_imt_2016_0093 crossref_primary_10_1016_j_cellimm_2016_12_006 crossref_primary_10_3389_fimmu_2020_609277 crossref_primary_10_1007_s00011_018_1198_8 |
| Cites_doi | 10.1182/blood-2003-11-3909 10.1182/blood-2007-02-075481 10.1038/ni.2077 10.1038/sj.leu.2404777 10.1016/S0002-9440(10)63365-2 10.4049/jimmunol.0803962 10.1089/scd.2013.0204 10.1146/annurev-pathol-011110-130230 10.1016/j.stem.2013.09.006 10.1182/blood-2010-12-324038 10.1038/nri2395 10.1146/annurev.pharmtox.010909.105600 10.1186/1471-2199-8-116 10.1089/scd.2010.0098 10.1016/j.ejphar.2007.01.025 10.1016/j.bbmt.2004.04.001 10.1038/3982 10.1038/sj.bmt.1704400 10.1021/bi101732n 10.1038/nri3209 10.1016/S0301-472X(01)00769-X 10.1186/scrt176 10.2741/e422 10.1038/mt.2009.157 10.1371/journal.pone.0047559 10.1158/1535-7163.MCT-10-0185 10.1189/jlb.0104046 10.1097/01.tp.0000214462.63943.14 10.1182/blood-2007-04-087056 10.1172/JCI28844 10.1080/14653240903193806 10.1038/mt.2011.189 10.1634/stemcells.2005-0008 10.1074/jbc.275.42.32688 10.1002/eji.200738129 10.1074/jbc.M604748200 10.1038/nm0302-240 10.1016/j.freeradbiomed.2004.07.008 10.1038/nri1457 10.4049/jimmunol.171.3.1572 10.1158/0008-5472.CAN-07-1872 10.1093/jnci/82.13.1107 10.1089/scd.2012.0594 10.1074/jbc.M111.312470 10.1073/pnas.91.13.5987 10.4049/jimmunol.0902007 10.1182/blood-2008-07-166892 10.1016/S0140-6736(08)60690-X |
| ContentType | Journal Article |
| Copyright | 2015 International Society for Cellular Therapy International Society for Cellular Therapy Copyright © 2015 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2015 International Society for Cellular Therapy – notice: International Society for Cellular Therapy – notice: Copyright © 2015 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.jcyt.2014.11.010 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1477-2566 |
| EndPage | 391 |
| ExternalDocumentID | 25595329 10_1016_j_jcyt_2014_11_010 S1465324914008810 1_s2_0_S1465324914008810 |
| Genre | Journal Article |
| GroupedDBID | --- --M .1- .FO .~1 1P~ 1~. 29F 36B 4.4 457 4G. 53G 5GY 5VS 7-5 8P~ AAAJQ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AATTM AAXKI AAXUO AAYWO ABDBF ABGSF ABJNI ABMAC ABMZM ABUDA ABXDB ACDAQ ACGEJ ACGFS ACIEU ACRLP ACUHS ACVFH ADBBV ADCNI ADCVX ADEZE ADXPE AEBSH AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFKVX AFPUW AFRHN AFTJW AFXIZ AGCQF AGEKW AGHFR AGRDE AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AJWEG AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AWYRJ AXJTR AZFZN BKOJK BLXMC BNPGV CAG CJTIS COF CS3 DU5 EAP EBC EBS EFJIC EFKBS EJD EMB EMK EMOBN ESX F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN GBLVA H13 HVGLF HZ~ KOM LUGTX M44 MO0 O-L O9. OAUVE OK~ P-8 P-9 P2P PC. Q38 R2- ROL SDF SPCBC SSH SSI SSU SSZ SV3 T5K TDBHL TFW Z5R ~G- AACTN AFCTW AFKWA AJOXV AMFUW AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c532t-e8b6f1d73af88d7953d5185da2dcf2dae56a56872a3c4a866db0f38118d5fc23 |
| IEDL.DBID | .~1 |
| ISSN | 1465-3249 1477-2566 |
| IngestDate | Fri Jul 11 07:59:35 EDT 2025 Mon Jul 21 06:03:14 EDT 2025 Tue Jul 01 03:06:09 EDT 2025 Thu Apr 24 22:53:06 EDT 2025 Mon Mar 31 10:57:53 EDT 2025 Sun Feb 23 10:18:47 EST 2025 Tue Aug 26 16:32:53 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | immune modulation indoleamine 2,3-dioxygenase mechanism of T-cell suppression inflammatory cytokine priming heme oxygenase 1 mesenchymal stromal cells |
| Language | English |
| License | Copyright © 2015 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c532t-e8b6f1d73af88d7953d5185da2dcf2dae56a56872a3c4a866db0f38118d5fc23 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 25595329 |
| PQID | 1662640715 |
| PQPubID | 23479 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_1662640715 pubmed_primary_25595329 crossref_primary_10_1016_j_jcyt_2014_11_010 crossref_citationtrail_10_1016_j_jcyt_2014_11_010 elsevier_sciencedirect_doi_10_1016_j_jcyt_2014_11_010 elsevier_clinicalkeyesjournals_1_s2_0_S1465324914008810 elsevier_clinicalkey_doi_10_1016_j_jcyt_2014_11_010 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2015-04-01 |
| PublicationDateYYYYMMDD | 2015-04-01 |
| PublicationDate_xml | – month: 04 year: 2015 text: 2015-04-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Cytotherapy (Oxford, England) |
| PublicationTitleAlternate | Cytotherapy |
| PublicationYear | 2015 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Lavrovsky, Schwartzman, Levere, Kappas, Abraham (bib22) 1994; 91 Gabunia, Ellison, Singh, Datta, Kelemen, Rizzo (bib35) 2012; 287 Romieu-Mourez, Coutu, Galipeau (bib16) 2012; 4 Singer, Caplan (bib18) 2011; 6 Krampera, Cosmi, Angeli, Pasini, Liotta, Andreini (bib17) 2006; 24 Ricchetti, Williams, Foxwell (bib36) 2004; 76 Bernardo, Fibbe (bib43) 2013; 13 Pallotta, Orabona, Volpi, Vacca, Belladonna, Bianchi (bib46) 2011; 12 Rafei, Birman, Forner, Galipeau (bib9) 2009; 17 Leautaud, Demple (bib40) 2007; 8 Polchert, Sobinsky, Douglas, Kidd, Moadsiri, Reina (bib8) 2008; 38 Kapturczak, Wasserfall, Brusko, Campbell-Thompson, Ellis, Atkinson (bib27) 2004; 165 Uccelli, Moretta, Pistoia (bib19) 2008; 8 Bartholomew, Sturgeon, Siatskas, Ferrer, McIntosh, Patil (bib6) 2002; 30 Araujo, Meng, Tward, Hancock, Zhai, Lee (bib29) 2003; 171 Metz, Duhadaway, Rust, Munn, Muller, Mautino (bib41) 2010; 9 Le Blanc, Mougiakakos (bib1) 2012; 12 Menard, Pacelli, Bassi, Dulong, Bifari, Bezier (bib38) 2013; 22 Kweon, Adhami, Lee, Mukhtar (bib37) 2006; 281 Le Blanc, Samuelsson, Gustafsson, Remberger, Sundberg, Arvidson (bib13) 2007; 21 Hancock, Buelow, Sayegh, Turka (bib31) 1998; 4 Mougiakakos, Jitschin, Johansson, Okita, Kiessling, Le Blanc (bib21) 2011; 117 Lalu, McIntyre, Pugliese, Fergusson, Winston, Marshall (bib11) 2012; 7 Di Trapani, Bassi, Ricciardi, Fontana, Bifari, Pacelli (bib47) 2013; 22 Chora, Fontoura, Cunha, Pais, Cardoso, Ho (bib28) 2007; 117 Terry, Clikeman, Hoidal, Callahan (bib23) 1998; 274 Skehan, Storeng, Scudiero, Monks, McMahon, Vistica (bib33) 1990; 82 Maitra, Szekely, Gjini, Laughlin, Dennis, Haynesworth (bib2) 2004; 33 Lee, Chau (bib34) 2002; 8 Efimov, Basran, Thackray, Handa, Mowat, Raven (bib45) 2011; 50 Mellor, Munn (bib44) 2004; 4 Ghannam, Pene, Torcy-Moquet, Jorgensen, Yssel (bib3) 2010; 185 Lin, Chiang, Lin, Shih, Liao, Hsu (bib24) 2007; 560 Kim, Vanella, Inoue, Burgess, Gotlinger, Manthati (bib48) 2010; 19 Vanella, Sodhi, Kim, Puri, Maheshwari, Hinds (bib49) 2013; 4 Ball, Bernardo, Roelofs, Lankester, Cometa, Egeler (bib12) 2007; 110 Battiwalla, Hematti (bib14) 2009; 11 Le Blanc, Frassoni, Ball, Locatelli, Roelofs, Lewis (bib15) 2008; 371 Rafei, Campeau, Aguilar-Mahecha, Buchanan, Williams, Birman (bib10) 2009; 182 Meisel, Zibert, Laryea, Gobel, Daubener, Dilloo (bib42) 2004; 103 Ringden, Uzunel, Rasmusson, Remberger, Sundberg, Lonnies (bib7) 2006; 81 Gozzelino, Jeney, Soares (bib26) 2010; 50 Chabannes, Hill, Merieau, Rossignol, Brion, Soulillou (bib20) 2007; 110 Metz, Duhadaway, Kamasani, Laury-Kleintop, Muller, Prendergast (bib32) 2007; 67 Exner, Minar, Wagner, Schillinger (bib25) 2004; 37 Rafei, Hsieh, Fortier, Li, Yuan, Birman (bib4) 2008; 112 Bouton, Demple (bib39) 2000; 275 Gerbitz, Ewing, Wilke, Schubert, Eissner, Dietl (bib30) 2004; 10 Francois, Romieu-Mourez, Li, Galipeau (bib5) 2012; 20 Kweon (10.1016/j.jcyt.2014.11.010_bib37) 2006; 281 Battiwalla (10.1016/j.jcyt.2014.11.010_bib14) 2009; 11 Kapturczak (10.1016/j.jcyt.2014.11.010_bib27) 2004; 165 Metz (10.1016/j.jcyt.2014.11.010_bib32) 2007; 67 Francois (10.1016/j.jcyt.2014.11.010_bib5) 2012; 20 Romieu-Mourez (10.1016/j.jcyt.2014.11.010_bib16) 2012; 4 Le Blanc (10.1016/j.jcyt.2014.11.010_bib1) 2012; 12 Gerbitz (10.1016/j.jcyt.2014.11.010_bib30) 2004; 10 Exner (10.1016/j.jcyt.2014.11.010_bib25) 2004; 37 Bernardo (10.1016/j.jcyt.2014.11.010_bib43) 2013; 13 Leautaud (10.1016/j.jcyt.2014.11.010_bib40) 2007; 8 Mougiakakos (10.1016/j.jcyt.2014.11.010_bib21) 2011; 117 Ball (10.1016/j.jcyt.2014.11.010_bib12) 2007; 110 Singer (10.1016/j.jcyt.2014.11.010_bib18) 2011; 6 Skehan (10.1016/j.jcyt.2014.11.010_bib33) 1990; 82 Rafei (10.1016/j.jcyt.2014.11.010_bib4) 2008; 112 Menard (10.1016/j.jcyt.2014.11.010_bib38) 2013; 22 Araujo (10.1016/j.jcyt.2014.11.010_bib29) 2003; 171 Vanella (10.1016/j.jcyt.2014.11.010_bib49) 2013; 4 Bouton (10.1016/j.jcyt.2014.11.010_bib39) 2000; 275 Meisel (10.1016/j.jcyt.2014.11.010_bib42) 2004; 103 Rafei (10.1016/j.jcyt.2014.11.010_bib10) 2009; 182 Krampera (10.1016/j.jcyt.2014.11.010_bib17) 2006; 24 Chabannes (10.1016/j.jcyt.2014.11.010_bib20) 2007; 110 Gabunia (10.1016/j.jcyt.2014.11.010_bib35) 2012; 287 Bartholomew (10.1016/j.jcyt.2014.11.010_bib6) 2002; 30 Lalu (10.1016/j.jcyt.2014.11.010_bib11) 2012; 7 Lavrovsky (10.1016/j.jcyt.2014.11.010_bib22) 1994; 91 Terry (10.1016/j.jcyt.2014.11.010_bib23) 1998; 274 Di Trapani (10.1016/j.jcyt.2014.11.010_bib47) 2013; 22 Ringden (10.1016/j.jcyt.2014.11.010_bib7) 2006; 81 Hancock (10.1016/j.jcyt.2014.11.010_bib31) 1998; 4 Metz (10.1016/j.jcyt.2014.11.010_bib41) 2010; 9 Ricchetti (10.1016/j.jcyt.2014.11.010_bib36) 2004; 76 Le Blanc (10.1016/j.jcyt.2014.11.010_bib13) 2007; 21 Le Blanc (10.1016/j.jcyt.2014.11.010_bib15) 2008; 371 Mellor (10.1016/j.jcyt.2014.11.010_bib44) 2004; 4 Lin (10.1016/j.jcyt.2014.11.010_bib24) 2007; 560 Ghannam (10.1016/j.jcyt.2014.11.010_bib3) 2010; 185 Maitra (10.1016/j.jcyt.2014.11.010_bib2) 2004; 33 Rafei (10.1016/j.jcyt.2014.11.010_bib9) 2009; 17 Pallotta (10.1016/j.jcyt.2014.11.010_bib46) 2011; 12 Uccelli (10.1016/j.jcyt.2014.11.010_bib19) 2008; 8 Lee (10.1016/j.jcyt.2014.11.010_bib34) 2002; 8 Efimov (10.1016/j.jcyt.2014.11.010_bib45) 2011; 50 Gozzelino (10.1016/j.jcyt.2014.11.010_bib26) 2010; 50 Kim (10.1016/j.jcyt.2014.11.010_bib48) 2010; 19 Chora (10.1016/j.jcyt.2014.11.010_bib28) 2007; 117 Polchert (10.1016/j.jcyt.2014.11.010_bib8) 2008; 38 |
| References_xml | – volume: 281 start-page: 33761 year: 2006 end-page: 33772 ident: bib37 article-title: Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate publication-title: J Biol Chem – volume: 37 start-page: 1097 year: 2004 end-page: 1104 ident: bib25 article-title: The role of heme oxygenase-1 promoter polymorphisms in human disease publication-title: Free radical biology & medicine – volume: 33 start-page: 597 year: 2004 end-page: 604 ident: bib2 article-title: Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation publication-title: Bone Marrow Transplant – volume: 76 start-page: 719 year: 2004 end-page: 726 ident: bib36 article-title: Heme oxygenase 1 expression induced by IL-10 requires STAT-3 and phosphoinositol-3 kinase and is inhibited by lipopolysaccharide publication-title: J Leukoc Biol – volume: 275 start-page: 32688 year: 2000 end-page: 32693 ident: bib39 article-title: Nitric oxide-inducible expression of heme oxygenase-1 in human cells. Translation-independent stabilization of the mRNA and evidence for direct action of nitric oxide publication-title: J Biol Chem – volume: 22 start-page: 1789 year: 2013 end-page: 1801 ident: bib38 article-title: Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls publication-title: Stem Cells Dev – volume: 185 start-page: 302 year: 2010 end-page: 312 ident: bib3 article-title: Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype publication-title: J Immunol – volume: 4 start-page: 1392 year: 1998 end-page: 1396 ident: bib31 article-title: Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes publication-title: Nat Med – volume: 6 start-page: 457 year: 2011 end-page: 478 ident: bib18 article-title: Mesenchymal stem cells: mechanisms of inflammation publication-title: Annu Rev Pathol – volume: 67 start-page: 7082 year: 2007 end-page: 7087 ident: bib32 article-title: Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan publication-title: Cancer Res – volume: 110 start-page: 2764 year: 2007 end-page: 2767 ident: bib12 article-title: Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation publication-title: Blood – volume: 7 start-page: e47559 year: 2012 ident: bib11 article-title: Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials publication-title: PloS One – volume: 560 start-page: 101 year: 2007 end-page: 109 ident: bib24 article-title: Transforming growth factor-beta1 stimulates heme oxygenase-1 expression via the PI3K/Akt and NF-kappaB pathways in human lung epithelial cells publication-title: Eur J Pharmacol – volume: 17 start-page: 1799 year: 2009 end-page: 1803 ident: bib9 article-title: Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis publication-title: Mol Ther – volume: 117 start-page: 4826 year: 2011 end-page: 4835 ident: bib21 article-title: The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells publication-title: Blood – volume: 287 start-page: 2477 year: 2012 end-page: 2484 ident: bib35 article-title: Interleukin-19 (IL-19) induces heme oxygenase-1 (HO-1) expression and decreases reactive oxygen species in human vascular smooth muscle cells publication-title: J Biol Chem – volume: 10 start-page: 461 year: 2004 end-page: 472 ident: bib30 article-title: Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone marrow transplantation publication-title: Biol Blood Marrow Transplant – volume: 38 start-page: 1745 year: 2008 end-page: 1755 ident: bib8 article-title: IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease publication-title: Eur J Immunol – volume: 50 start-page: 323 year: 2010 end-page: 354 ident: bib26 article-title: Mechanisms of cell protection by heme oxygenase-1 publication-title: Annu Rev Pharmacol Toxicol – volume: 8 start-page: 116 year: 2007 ident: bib40 article-title: Regulation of heme oxygenase-1 mRNA deadenylation and turnover in NIH3T3 cells by nitrosative or alkylation stress publication-title: BMC Mol Biol – volume: 103 start-page: 4619 year: 2004 end-page: 4621 ident: bib42 article-title: Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation publication-title: Blood – volume: 171 start-page: 1572 year: 2003 end-page: 1580 ident: bib29 article-title: Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse publication-title: J Immunol – volume: 274 start-page: H883 year: 1998 end-page: H891 ident: bib23 article-title: Effect of tumor necrosis factor-alpha and interleukin-1 alpha on heme oxygenase-1 expression in human endothelial cells publication-title: Am J Physiol – volume: 11 start-page: 503 year: 2009 end-page: 515 ident: bib14 article-title: Mesenchymal stem cells in hematopoietic stem cell transplantation publication-title: Cytotherapy – volume: 182 start-page: 5994 year: 2009 end-page: 6002 ident: bib10 article-title: Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner publication-title: J Immunol – volume: 91 start-page: 5987 year: 1994 end-page: 5991 ident: bib22 article-title: Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene publication-title: Proc Natl Acad Sci U S A – volume: 19 start-page: 1863 year: 2010 end-page: 1873 ident: bib48 article-title: Epoxyeicosatrienoic acid agonist regulates human mesenchymal stem cell-derived adipocytes through activation of HO-1-pAKT signaling and a decrease in PPARgamma publication-title: Stem Cells Dev – volume: 81 start-page: 1390 year: 2006 end-page: 1397 ident: bib7 article-title: Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease publication-title: Transplantation – volume: 371 start-page: 1579 year: 2008 end-page: 1586 ident: bib15 article-title: Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study publication-title: Lancet – volume: 112 start-page: 4991 year: 2008 end-page: 4998 ident: bib4 article-title: Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction publication-title: Blood – volume: 12 start-page: 870 year: 2011 end-page: 878 ident: bib46 article-title: Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells publication-title: Nat Immunol – volume: 82 start-page: 1107 year: 1990 end-page: 1112 ident: bib33 article-title: New colorimetric cytotoxicity assay for anticancer-drug screening publication-title: J Natl Cancer Inst – volume: 8 start-page: 240 year: 2002 end-page: 246 ident: bib34 article-title: Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice publication-title: Nat Med – volume: 9 start-page: 1864 year: 2010 end-page: 1871 ident: bib41 article-title: Zinc protoporphyrin IX stimulates tumor immunity by disrupting the immunosuppressive enzyme indoleamine 2,3-dioxygenase publication-title: Mol Cancer Ther – volume: 4 start-page: 28 year: 2013 ident: bib49 article-title: Increased heme-oxygenase 1 expression in mesenchymal stem cell-derived adipocytes decreases differentiation and lipid accumulation via upregulation of the canonical Wnt signaling cascade publication-title: Stem Cell Res Ther – volume: 13 start-page: 392 year: 2013 end-page: 402 ident: bib43 article-title: Mesenchymal stromal cells: sensors and switchers of inflammation publication-title: Cell Stem Cell – volume: 8 start-page: 726 year: 2008 end-page: 736 ident: bib19 article-title: Mesenchymal stem cells in health and disease publication-title: Nat Rev Immunol – volume: 20 start-page: 187 year: 2012 end-page: 195 ident: bib5 article-title: Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation publication-title: Mol Ther – volume: 110 start-page: 3691 year: 2007 end-page: 3694 ident: bib20 article-title: A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells publication-title: Blood – volume: 21 start-page: 1733 year: 2007 end-page: 1738 ident: bib13 article-title: Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells publication-title: Leukemia – volume: 165 start-page: 1045 year: 2004 end-page: 1053 ident: bib27 article-title: Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse publication-title: Am J Pathol – volume: 117 start-page: 438 year: 2007 end-page: 447 ident: bib28 article-title: Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation publication-title: J Clin Invest – volume: 22 start-page: 2990 year: 2013 end-page: 3002 ident: bib47 article-title: Comparative study of immune regulatory properties of stem cells derived from different tissues publication-title: Stem Cells Dev – volume: 50 start-page: 2717 year: 2011 end-page: 2724 ident: bib45 article-title: Structure and reaction mechanism in the heme dioxygenases publication-title: Biochemistry – volume: 30 start-page: 42 year: 2002 end-page: 48 ident: bib6 article-title: Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo publication-title: Exp Hematol – volume: 4 start-page: 824 year: 2012 end-page: 837 ident: bib16 article-title: The immune plasticity of mesenchymal stromal cells from mice and men: concordances and discrepancies publication-title: Front Biosci (Elite Ed) – volume: 4 start-page: 762 year: 2004 end-page: 774 ident: bib44 article-title: IDO expression by dendritic cells: tolerance and tryptophan catabolism publication-title: Nat Rev Immunol – volume: 24 start-page: 386 year: 2006 end-page: 398 ident: bib17 article-title: Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells publication-title: Stem Cells – volume: 12 start-page: 383 year: 2012 end-page: 396 ident: bib1 article-title: Multipotent mesenchymal stromal cells and the innate immune system publication-title: Nat Rev Immunol – volume: 103 start-page: 4619 year: 2004 ident: 10.1016/j.jcyt.2014.11.010_bib42 article-title: Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation publication-title: Blood doi: 10.1182/blood-2003-11-3909 – volume: 110 start-page: 3691 year: 2007 ident: 10.1016/j.jcyt.2014.11.010_bib20 article-title: A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells publication-title: Blood doi: 10.1182/blood-2007-02-075481 – volume: 12 start-page: 870 year: 2011 ident: 10.1016/j.jcyt.2014.11.010_bib46 article-title: Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells publication-title: Nat Immunol doi: 10.1038/ni.2077 – volume: 21 start-page: 1733 year: 2007 ident: 10.1016/j.jcyt.2014.11.010_bib13 article-title: Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells publication-title: Leukemia doi: 10.1038/sj.leu.2404777 – volume: 165 start-page: 1045 year: 2004 ident: 10.1016/j.jcyt.2014.11.010_bib27 article-title: Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)63365-2 – volume: 182 start-page: 5994 year: 2009 ident: 10.1016/j.jcyt.2014.11.010_bib10 article-title: Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner publication-title: J Immunol doi: 10.4049/jimmunol.0803962 – volume: 22 start-page: 2990 year: 2013 ident: 10.1016/j.jcyt.2014.11.010_bib47 article-title: Comparative study of immune regulatory properties of stem cells derived from different tissues publication-title: Stem Cells Dev doi: 10.1089/scd.2013.0204 – volume: 6 start-page: 457 year: 2011 ident: 10.1016/j.jcyt.2014.11.010_bib18 article-title: Mesenchymal stem cells: mechanisms of inflammation publication-title: Annu Rev Pathol doi: 10.1146/annurev-pathol-011110-130230 – volume: 13 start-page: 392 year: 2013 ident: 10.1016/j.jcyt.2014.11.010_bib43 article-title: Mesenchymal stromal cells: sensors and switchers of inflammation publication-title: Cell Stem Cell doi: 10.1016/j.stem.2013.09.006 – volume: 117 start-page: 4826 year: 2011 ident: 10.1016/j.jcyt.2014.11.010_bib21 article-title: The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells publication-title: Blood doi: 10.1182/blood-2010-12-324038 – volume: 8 start-page: 726 year: 2008 ident: 10.1016/j.jcyt.2014.11.010_bib19 article-title: Mesenchymal stem cells in health and disease publication-title: Nat Rev Immunol doi: 10.1038/nri2395 – volume: 50 start-page: 323 year: 2010 ident: 10.1016/j.jcyt.2014.11.010_bib26 article-title: Mechanisms of cell protection by heme oxygenase-1 publication-title: Annu Rev Pharmacol Toxicol doi: 10.1146/annurev.pharmtox.010909.105600 – volume: 8 start-page: 116 year: 2007 ident: 10.1016/j.jcyt.2014.11.010_bib40 article-title: Regulation of heme oxygenase-1 mRNA deadenylation and turnover in NIH3T3 cells by nitrosative or alkylation stress publication-title: BMC Mol Biol doi: 10.1186/1471-2199-8-116 – volume: 19 start-page: 1863 year: 2010 ident: 10.1016/j.jcyt.2014.11.010_bib48 article-title: Epoxyeicosatrienoic acid agonist regulates human mesenchymal stem cell-derived adipocytes through activation of HO-1-pAKT signaling and a decrease in PPARgamma publication-title: Stem Cells Dev doi: 10.1089/scd.2010.0098 – volume: 560 start-page: 101 year: 2007 ident: 10.1016/j.jcyt.2014.11.010_bib24 article-title: Transforming growth factor-beta1 stimulates heme oxygenase-1 expression via the PI3K/Akt and NF-kappaB pathways in human lung epithelial cells publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2007.01.025 – volume: 10 start-page: 461 year: 2004 ident: 10.1016/j.jcyt.2014.11.010_bib30 article-title: Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone marrow transplantation publication-title: Biol Blood Marrow Transplant doi: 10.1016/j.bbmt.2004.04.001 – volume: 4 start-page: 1392 year: 1998 ident: 10.1016/j.jcyt.2014.11.010_bib31 article-title: Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes publication-title: Nat Med doi: 10.1038/3982 – volume: 33 start-page: 597 year: 2004 ident: 10.1016/j.jcyt.2014.11.010_bib2 article-title: Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation publication-title: Bone Marrow Transplant doi: 10.1038/sj.bmt.1704400 – volume: 50 start-page: 2717 year: 2011 ident: 10.1016/j.jcyt.2014.11.010_bib45 article-title: Structure and reaction mechanism in the heme dioxygenases publication-title: Biochemistry doi: 10.1021/bi101732n – volume: 12 start-page: 383 year: 2012 ident: 10.1016/j.jcyt.2014.11.010_bib1 article-title: Multipotent mesenchymal stromal cells and the innate immune system publication-title: Nat Rev Immunol doi: 10.1038/nri3209 – volume: 30 start-page: 42 year: 2002 ident: 10.1016/j.jcyt.2014.11.010_bib6 article-title: Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo publication-title: Exp Hematol doi: 10.1016/S0301-472X(01)00769-X – volume: 4 start-page: 28 year: 2013 ident: 10.1016/j.jcyt.2014.11.010_bib49 article-title: Increased heme-oxygenase 1 expression in mesenchymal stem cell-derived adipocytes decreases differentiation and lipid accumulation via upregulation of the canonical Wnt signaling cascade publication-title: Stem Cell Res Ther doi: 10.1186/scrt176 – volume: 4 start-page: 824 year: 2012 ident: 10.1016/j.jcyt.2014.11.010_bib16 article-title: The immune plasticity of mesenchymal stromal cells from mice and men: concordances and discrepancies publication-title: Front Biosci (Elite Ed) doi: 10.2741/e422 – volume: 17 start-page: 1799 year: 2009 ident: 10.1016/j.jcyt.2014.11.010_bib9 article-title: Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis publication-title: Mol Ther doi: 10.1038/mt.2009.157 – volume: 7 start-page: e47559 year: 2012 ident: 10.1016/j.jcyt.2014.11.010_bib11 article-title: Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials publication-title: PloS One doi: 10.1371/journal.pone.0047559 – volume: 9 start-page: 1864 year: 2010 ident: 10.1016/j.jcyt.2014.11.010_bib41 article-title: Zinc protoporphyrin IX stimulates tumor immunity by disrupting the immunosuppressive enzyme indoleamine 2,3-dioxygenase publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-10-0185 – volume: 76 start-page: 719 year: 2004 ident: 10.1016/j.jcyt.2014.11.010_bib36 article-title: Heme oxygenase 1 expression induced by IL-10 requires STAT-3 and phosphoinositol-3 kinase and is inhibited by lipopolysaccharide publication-title: J Leukoc Biol doi: 10.1189/jlb.0104046 – volume: 81 start-page: 1390 year: 2006 ident: 10.1016/j.jcyt.2014.11.010_bib7 article-title: Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease publication-title: Transplantation doi: 10.1097/01.tp.0000214462.63943.14 – volume: 110 start-page: 2764 year: 2007 ident: 10.1016/j.jcyt.2014.11.010_bib12 article-title: Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation publication-title: Blood doi: 10.1182/blood-2007-04-087056 – volume: 274 start-page: H883 issue: 3 Pt 2 year: 1998 ident: 10.1016/j.jcyt.2014.11.010_bib23 article-title: Effect of tumor necrosis factor-alpha and interleukin-1 alpha on heme oxygenase-1 expression in human endothelial cells publication-title: Am J Physiol – volume: 117 start-page: 438 year: 2007 ident: 10.1016/j.jcyt.2014.11.010_bib28 article-title: Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation publication-title: J Clin Invest doi: 10.1172/JCI28844 – volume: 11 start-page: 503 year: 2009 ident: 10.1016/j.jcyt.2014.11.010_bib14 article-title: Mesenchymal stem cells in hematopoietic stem cell transplantation publication-title: Cytotherapy doi: 10.1080/14653240903193806 – volume: 20 start-page: 187 year: 2012 ident: 10.1016/j.jcyt.2014.11.010_bib5 article-title: Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation publication-title: Mol Ther doi: 10.1038/mt.2011.189 – volume: 24 start-page: 386 year: 2006 ident: 10.1016/j.jcyt.2014.11.010_bib17 article-title: Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells publication-title: Stem Cells doi: 10.1634/stemcells.2005-0008 – volume: 275 start-page: 32688 year: 2000 ident: 10.1016/j.jcyt.2014.11.010_bib39 article-title: Nitric oxide-inducible expression of heme oxygenase-1 in human cells. Translation-independent stabilization of the mRNA and evidence for direct action of nitric oxide publication-title: J Biol Chem doi: 10.1074/jbc.275.42.32688 – volume: 38 start-page: 1745 year: 2008 ident: 10.1016/j.jcyt.2014.11.010_bib8 article-title: IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease publication-title: Eur J Immunol doi: 10.1002/eji.200738129 – volume: 281 start-page: 33761 year: 2006 ident: 10.1016/j.jcyt.2014.11.010_bib37 article-title: Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate publication-title: J Biol Chem doi: 10.1074/jbc.M604748200 – volume: 8 start-page: 240 year: 2002 ident: 10.1016/j.jcyt.2014.11.010_bib34 article-title: Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice publication-title: Nat Med doi: 10.1038/nm0302-240 – volume: 37 start-page: 1097 year: 2004 ident: 10.1016/j.jcyt.2014.11.010_bib25 article-title: The role of heme oxygenase-1 promoter polymorphisms in human disease publication-title: Free radical biology & medicine doi: 10.1016/j.freeradbiomed.2004.07.008 – volume: 4 start-page: 762 year: 2004 ident: 10.1016/j.jcyt.2014.11.010_bib44 article-title: IDO expression by dendritic cells: tolerance and tryptophan catabolism publication-title: Nat Rev Immunol doi: 10.1038/nri1457 – volume: 171 start-page: 1572 year: 2003 ident: 10.1016/j.jcyt.2014.11.010_bib29 article-title: Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse publication-title: J Immunol doi: 10.4049/jimmunol.171.3.1572 – volume: 67 start-page: 7082 year: 2007 ident: 10.1016/j.jcyt.2014.11.010_bib32 article-title: Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-1872 – volume: 82 start-page: 1107 year: 1990 ident: 10.1016/j.jcyt.2014.11.010_bib33 article-title: New colorimetric cytotoxicity assay for anticancer-drug screening publication-title: J Natl Cancer Inst doi: 10.1093/jnci/82.13.1107 – volume: 22 start-page: 1789 year: 2013 ident: 10.1016/j.jcyt.2014.11.010_bib38 article-title: Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls publication-title: Stem Cells Dev doi: 10.1089/scd.2012.0594 – volume: 287 start-page: 2477 year: 2012 ident: 10.1016/j.jcyt.2014.11.010_bib35 article-title: Interleukin-19 (IL-19) induces heme oxygenase-1 (HO-1) expression and decreases reactive oxygen species in human vascular smooth muscle cells publication-title: J Biol Chem doi: 10.1074/jbc.M111.312470 – volume: 91 start-page: 5987 year: 1994 ident: 10.1016/j.jcyt.2014.11.010_bib22 article-title: Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.91.13.5987 – volume: 185 start-page: 302 year: 2010 ident: 10.1016/j.jcyt.2014.11.010_bib3 article-title: Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype publication-title: J Immunol doi: 10.4049/jimmunol.0902007 – volume: 112 start-page: 4991 year: 2008 ident: 10.1016/j.jcyt.2014.11.010_bib4 article-title: Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction publication-title: Blood doi: 10.1182/blood-2008-07-166892 – volume: 371 start-page: 1579 year: 2008 ident: 10.1016/j.jcyt.2014.11.010_bib15 article-title: Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study publication-title: Lancet doi: 10.1016/S0140-6736(08)60690-X |
| SSID | ssj0020885 |
| Score | 2.125977 |
| Snippet | Mesenchymal stromal cells deploy immune suppressive properties amenable for use as cell therapy for inflammatory disorders. It is now recognized that... Abstract Mesenchymal stromal cells deploy immune suppressive properties amenable for use as cell therapy for inflammatory disorders. It is now recognized that... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 382 |
| SubjectTerms | Adolescent Adult Advanced Basic Science Cell Proliferation Cell- and Tissue-Based Therapy Cells, Cultured Female Heme - metabolism heme oxygenase 1 Heme Oxygenase-1 - antagonists & inhibitors Heme Oxygenase-1 - metabolism Humans immune modulation Immune Tolerance indoleamine 2,3-dioxygenase Indoleamine-Pyrrole 2,3,-Dioxygenase - metabolism Inflammation - therapy inflammatory cytokine priming Interferon-gamma - immunology Interferon-gamma - pharmacology Lymphocyte Activation - immunology Male mechanism of T-cell suppression mesenchymal stromal cells Mesenchymal Stromal Cells - enzymology Mesenchymal Stromal Cells - immunology Metalloporphyrins - pharmacology Other Protoporphyrins - pharmacology T-Lymphocytes - immunology Transforming Growth Factor beta - metabolism Tumor Necrosis Factor-alpha - metabolism Young Adult |
| Title | Human mesenchymal stromal cells suppress T-cell proliferation independent of heme oxygenase-1 |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1465324914008810 https://www.clinicalkey.es/playcontent/1-s2.0-S1465324914008810 https://dx.doi.org/10.1016/j.jcyt.2014.11.010 https://www.ncbi.nlm.nih.gov/pubmed/25595329 https://www.proquest.com/docview/1662640715 |
| Volume | 17 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9wwDBele9nL2PduW4sLoy9revly7DyWsnLdWCnsBn0ZxnFseqV3OZocLC_72yvFScpY18GeQhw7SizJkox-MsAHKxNpclRA61wepIVJAo12EWUZfesiCXPbodK-nmWz7-nnC36xBccDFobSKvu136_p3Wrdt0z72ZyuF4vpt4hKg2H0gCECqkoHs0pTQVJ--GtM84jxEfcIIx5Q7x4443O8rkxL-ZRRekiVPAlFe79x-pvz2Rmhk6fwpPce2ZH_wGewZVfPYf_cl59uD9j8Dk1VH7B9dn5XmLp9AT-6HXu2JMCRuWyX-Ka6uanoSvv3Nas36y4vls0DamBrOtLHWS8kbDGemNuwyrFLu7Ss-tmiBKIlDKKXMD_5ND-eBf3xCoHBeWsCK4vMRaVItJOyFDlPSo7Wu9RxaVxcasszzTMpYp2YVMssK4vQoYGPZMmdiZNXsL2qVvYNsDA0knNTYPQTpY4brZ0oQikcRkvC5mIC0TCtyvSlx-kEjGs15JhdKWKFIlZgTKKQFRP4OI5Z-8IbD_ZOBm6pAVKKi6BCu_DgKHHfKFv3elyrSNWxCtUfsjYBPo78TVz_SXFvECWFeky81CtbbZBShpNF0TWfwGsvY-N_U9iH5PO3_0n1HTzGO-4Tjt7DdnOzsTvoSzXFbqcsu_Do6PTL7OwW8RoeJA |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEB9K-6AvYv08rbqC9MWml69NNo9SLKe2pWCEvsiy2ezSK97laHLQvPRv70w2SRFrBZ8C-5FNdmZ2Zpb5zQB8MCISOkMBNNZmXlzoyFOoF5GX0bYuIj8zHSrt-CSZ_Yi_nvGzDTgYsDAUVtmf_e5M707rvmXa7-Z0NZ9PvweUGgy9B3QRUFQIZrUVo_hSGYP96zHOI8Q-7iBG3KPhPXLGBXld6JYCKoN4n1J5Eoz2bu30N-uz00KHj-FRbz6yT-4Lt2HDLJ_A7qnLP93usfwWTlXvsV12epuZun0KP7sre7YgxJE-bxf4prq5rOhJF_g1q9erLjCW5R41sBXV9LHGcQmbjyVzG1ZZdm4WhlVXLbIgqkIveAb54ef8YOb19RU8jRvXeEYUiQ3KNFJWiDLNeFRyVN-lCkttw1IZniieiDRUkY6VSJKy8C1q-ECU3Ooweg6by2ppXgLzfS041wW6P0FsuVbKpoUvUovuUmqydALBsK1S97nHqQTGLzkEmV1IIoUkUqBTIpEUE_g4zlm5zBv3jo4GaskBU4qnoETFcO-s9K5Zpu4FuZaBrEPpyz-YbQJ8nPkbv_5zxfcDK0kUZKKlWppqjSsluFnkXvMJvHA8Nv43-X24fPbqP1d9Bw9m-fGRPPpy8u01PMQe7qKPdmCzuVybN2hYNcXbTnBuAEWQH7I |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human+mesenchymal+stromal+cells+suppress+T-cell+proliferation+independent+of+heme+oxygenase-1&rft.jtitle=Cytotherapy+%28Oxford%2C+England%29&rft.au=Patel%2C+Seema+R.&rft.au=Copland%2C+Ian+B.&rft.au=Garcia%2C+Marco+A.&rft.au=Metz%2C+Richard&rft.date=2015-04-01&rft.issn=1465-3249&rft.volume=17&rft.issue=4&rft.spage=382&rft.epage=391&rft_id=info:doi/10.1016%2Fj.jcyt.2014.11.010&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jcyt_2014_11_010 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F14653249%2FS1465324914X00162%2Fcov150h.gif |